SGLT2 INHIBITORS IN IGA NEPHROPATHY: REAL-WORLD CLINICAL PRACTICE

被引：0
|
作者：
Garcia Carro, Clara [1 ]
Aiffil Meneses, Arianne [1 ]
Lopez Martinez, Marina [2 ]
Velo, Mercedes [1 ]
Rodriguez-Moreno, Antolina [1 ]
Soler Romeo, Maria Jose [2 ]
Sanchez Fructuoso, Ana [1 ]
机构：
[1] San Carlos Univ Clin Hosp, Nephrol, Madrid, Spain
[2] Vall dHebron Univ Hosp, Nephrol, Barcelona, Spain
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
5814
引用
收藏
页码：I397 / I398
页数：2
相关论文
共 50 条
  • [31] SGLT2 Inhibitors Are Associated With Reduced Cardiovascular Disease in Patients With Type 2 Diabetes: An Analysis of Real-World Data
    Wang, Wendy
    Chen, Lin Yee
    Walker, Rob F.
    Chow, Lisa S.
    Norby, Faye L.
    Alonso, Alvaro
    Pankow, James S.
    Lutsey, Pamela L.
    [J]. MAYO CLINIC PROCEEDINGS, 2023, 98 (07) : 985 - 996
  • [32] Real-World Evidence Demonstrating The Association Of SGLT2 Inhibitors With Reduced Cardiovascular Disease In Patients With Type 2 Diabetes
    Wang, Wendy
    Chen, Lin Y.
    Walker, Rob
    Chow, Lisa
    Norby, Faye L.
    Alonso, Alvaro
    Pankow, Jim S.
    Lutsey, Pamela L.
    [J]. CIRCULATION, 2022, 145
  • [33] Kidney outcomes of SGLT2 inhibitors among older patients with diabetic kidney disease in real-world clinical practice: the Japan Chronic Kidney Disease Database Ex
    Kitaoka, Kaori
    Yano, Yuichiro
    Nagasu, Hajime
    Kanegae, Hiroshi
    Chishima, Noriharu
    Akiyama, Hiroki
    Tamura, Kouichi
    Kashihara, Naoki
    [J]. BMJ OPEN DIABETES RESEARCH & CARE, 2024, 12 (03)
  • [34] Kidney Outcomes Associated With SGLT2 Inhibitors Versus Other Glucose-Lowering Drugs in Real-world Clinical Practice: The Japan Chronic Kidney Disease Database
    Nagasu, Hajime
    Yano, Yuichiro
    Kanegae, Hiroshi
    Heerspink, Hiddo J. L.
    Nangaku, Masaomi
    Hirakawa, Yosuke
    Sugawara, Yuka
    Nakagawa, Naoki
    Tani, Yuji
    Wada, Jun
    Sugiyama, Hitoshi
    Tsuruya, Kazuhiko
    Nakano, Toshiaki
    Maruyama, Shoichi
    Wada, Takashi
    Yamagata, Kunihiro
    Narita, Ichiei
    Tamura, Kouichi
    Yanagita, Motoko
    Terada, Yoshio
    Shigematsu, Takashi
    Sofue, Tadashi
    Ito, Takafumi
    Okada, Hirokazu
    Nakashima, Naoki
    Kataoka, Hiromi
    Ohe, Kazuhiko
    Okada, Mihoko
    Itano, Seiji
    Nishiyama, Akira
    Kanda, Eiichiro
    Ueki, Kohjiro
    Kashihara, Naoki
    [J]. DIABETES CARE, 2021, 44 (11) : 2542 - 2551
  • [35] SGLT2 inhibitors as add on therapy in type 2 diabetes: A real world study
    Tamez-Perez H.E.
    Delgadillo-Esteban E.
    Soni-Duque D.
    Hernández-Coria M.I.
    Tamez-Peña A.L.
    [J]. Journal of Diabetes & Metabolic Disorders, 16 (1):
  • [36] THE ROLE OF INHIBITORS SGLT2 IN DIABETIC NEPHROPATHY; LITERATURE REVIEW
    Allihybi, Sultan Mohammad
    Alshammari, Rakan Ayyadah
    Alshammari, Basil Ayyadah
    Althobaiti, Khalid Turki
    Almufarriji, Futun Flamed
    Almuqaytib, Ahmed Yousef
    Alrebeh, Doaa Mohammed
    Almadeh, Zahra Mandi
    Alhulw, Fatimah Ali
    Al Abdrabalnabi, Fatimah Ahmed
    [J]. PHARMACOPHORE, 2021, 12 (05): : 81 - 84
  • [37] SGLT2 inhibitors might halt progression of diabetic nephropathy
    Yamout, Hala
    Bakris, George L.
    [J]. NATURE REVIEWS NEPHROLOGY, 2016, 12 (10) : 583 - 584
  • [38] SGLT2 inhibitors might halt progression of diabetic nephropathy
    Hala Yamout
    George L. Bakris
    [J]. Nature Reviews Nephrology, 2016, 12 : 583 - 584
  • [39] EFFECTS OF SGLT2 INHIBITORS ON DIABETIC NEPHROPATHY: PODOCYTURIA ON FOCUS
    Ozkan, Serbay
    Saygi, Halil Ibrahim
    Korkmaz, Ozge Polat
    Durcan, Emre
    Murt, Ahmet
    Sahin, Serdar
    Dincer, Mevlut Tamer
    Bakir, Alev
    Ozkaya, Hande Mefkure
    Trabulus, Sinan
    Seyahi, Nurhan
    Guzel, Elif
    Gonen, Mustafa Sait
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1332 - 1332
  • [40] The growing clinical effect of SGLT2 inhibitors
    Del Prato, Stefano
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2023, 11 (04): : 218 - 219
12345